Insights

Providing the latest information from our experts at Forge
Read More
October, 17 2023 in
Starting With the End in Mind

Starting With the End in Mind

23 Questions with Claire Marasco on Global Regulatory Strategies Read More
September, 11 2023 in
23 Questions With Claire Marasco on Global Regulatory Strategies

23 Questions with Claire Marasco on Global Regulatory Strategies

Read More
April, 3 2023 in
Forge Biologics’ cGMP Compliant and Commercially Viable Bespoke Affinity Chromatography Platform

Forge Biologics’ cGMP Compliant and Commercially Viable Bespoke Affinity Chromatography...

Read More
February, 11 2023 in
Celebrating Women at Forge for International Day of Women and Girls in Science

Read More
December, 1 2022 in
Streamline the AAV Manufacturing Process with High-Grade Starting Materials

 Streamline the AAV Manufacturing Process with High-Grade Starting Materials Authors:

Read More
November, 16 2022 in
Innovative Analytical Ultracentrifugation Techniques for the Characterization of AAV Vectors

Authors:

Read More
November, 3 2022 in
What the DMF! Spotlight on Forge's Drug Master File

Gene therapy developers' Investigational New Drug (IND) application process is arduous...

Read More
August, 23 2022 in
She Forges Turns 1: Reflecting on a Year of Celebrating, Supporting, and Elevating Women at Forge

Read More
August, 12 2022 in
Addressing the ‘Capacity Crunch’ with a Scalable Platform Process Approach

Authors: Brianna Barrett, Ph.D., Associate Director, Technical Sales, Forge Biologics ...

Read More
June, 30 2022 in
Tackling CMC Challenges with ARM's Project A-Gene